|
Título:
|
Low Phytanic Acid-Concentrated DHA Prevents Cognitive Deficit and Regulates Alzheimer Disease Mediators in an ApoE?/? Mice Experimental Model
|
|
Autores:
|
Ruiz-Roso Guerra, María Belén ;
Echeverry Alzate, Víctor ;
Ruiz-Roso Calvo de la Mora, Baltasar ;
Quintela, José ;
Ballesteros Rodrigálvarez, Sandra ;
Lahera Julia, Vicente ;
Heras Jiménez, Natalia de las ;
López Moreno, José Antonio ;
Martín Fernández, Beatriz
|
|
Tipo de documento:
|
texto impreso
|
|
Editorial:
|
MDPI, 2018
|
|
Dimensiones:
|
application/pdf
|
|
Nota general:
|
cc_by
info:eu-repo/semantics/openAccess
|
|
Idiomas:
|
|
|
Palabras clave:
|
Estado = Publicado
,
Materia = Ciencias Biomédicas: Medicina: Neurociencias
,
Tipo = Artículo
|
|
Resumen:
|
Alzheimer’s disease (AD) is the main cause of dementia and cognitive impairment. It has been associated with a significant diminution of omega-3 polyunsaturated fatty acid docosahexaenoic acid (DHA) levels in the brain. Clinical trials with DHA as a treatment in neurological diseases have shown inconsistent results. Previously, we reported that the presence of phytanic acid (PhA) in standard DHA compositions could be blunting DHA’s beneficial effects. Therefore, we aimed to analyze the effects of a low PhA-concentrated DHA and a standard PhA-concentrated DHA in Apolipoprotein E knockout (ApoE
|
|
En línea:
|
https://eprints.ucm.es/id/eprint/62162/1/nutrients-11-00011-v2.pdf
|
